기사

PRODIZEN Co., Ltd., a company specializing in regenerative medicine medical devices, has visited the Philippines as part of its full-scale efforts to obtain local regulatory approval for its PRS Kit and enter the country’s aesthetic medicine market.

The visit was organized to develop a more concrete market-entry strategy by examining the rapidly growing Philippine aesthetic market and the local medical device distribution landscape, while reviewing the progress of the PRS Kit’s regulatory approval process. PRODIZEN discussed product registration procedures and future cooperation plans with local stakeholders. The company also closely assessed demand and business conditions in the Philippine medical and aesthetic sectors, laying the groundwork for further global market expansion.

PRODIZEN’s PRS Kit is a medical device developed to efficiently prepare platelet-rich plasma (PRP) from a patient’s own blood. It is designed to provide healthcare professionals with ease of use and consistent separation of blood components. The kit is currently used by various medical institutions, and its range of applications continues to expand through ongoing research and clinical use in regenerative medicine.

Since its establishment in 1998, PRODIZEN has positioned itself as a leading company in South Korea’s regenerative medicine medical device market. Through its subsidiary, Medisarang, the company commercialized South Korea’s first PRP product. It also independently develops and manufactures a range of regenerative medicine devices, including PRP separation kits, bone marrow concentrate (BMC) kits, and dedicated centrifuges.

PRODIZEN is also expanding its presence in international markets based on compliance with global quality standards, including U.S. FDA registration and European CE certification. Through continuous research and development and enhanced quality competitiveness, the company is strengthening its position as a global regenerative medicine medical device provider.

A PRODIZEN representative said, “Our visit to the Philippines provided a valuable opportunity to advance the local regulatory approval process for the PRS Kit and directly assess the growth potential of the Philippine aesthetic market and the needs of healthcare professionals.”

The representative added, “Building on this visit, we plan to further strengthen cooperation with our local partners, successfully introduce the PRS Kit to the Philippine market, and continue expanding our presence across Southeast Asia.”

Source: Medi Consumer News